Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!
Eur Respir J
.
2018 May 10;51(5):1800730.
doi: 10.1183/13993003.00730-2018.
Print 2018 May.
Author
William W Busse
1
Affiliation
1
Dept of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA wwb@medicine.wisc.edu.
PMID:
29748244
DOI:
10.1183/13993003.00730-2018
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
Asthma
Eosinophils*
Humans
Omalizumab*
Substances
Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
Omalizumab